Contraceptive News and Research

RSS

Go-ahead for HIV computer game

A ground breaking computer game developed by a University of Salford lecturer to help educate young South Africans about the dangers of HIV and AIDS will be piloted in July.

1 Jun 2005

Organon obtains license for Merck's novel oral contraceptive

Akzo Nobel's human healthcare business, Organon, has been granted worldwide development and marketing rights by Merck KGaA affiliate Laboratoire Théramex for its novel oral contraceptive EMM 310066.

1 Jun 2005

New information on reproductive health in St Petersburg

Abortions are still very common in St Petersburg, as is the use of unreliable contraceptives, despite the fact that sexual education reaches out to young people better than before. The social change is especially evident from the active sexual behaviour among young men.

1 Jun 2005

Washington saw its lowest teen pregnancy rate in more than two decades

That year, the number of pregnancies per 1,000 women ages 15 to 19 was 53.2 - the lowest rate seen since 1980 when reporting first began and the teen pregnancy rate was 95.4.

30 May 2005

Taking the contraceptive pill may permanently supress womens libido

According to their research, a team at Boston University Medical College found that women who take the pill regularly have much lower levels of the hormone that drives sexual desire, and even more worrying, that hormone remains suppressed even when they come off the pill.

29 May 2005

Asthma and hay fever seem to be linked to irregular periods

The finding adds weight to the evidence, suggesting that female hormones might have a role in the development of asthma and allergies.

25 May 2005

Impact of oral contraceptives not immediately reversible after discontinuation

Hormonal changes induced by oral contraceptives (OC) are not immediately reversible after discontinuation of use, according to new research issued today at the American Association of Clinical Endocrinologists (AACE) Fourteenth Annual Meeting and Clinical Congress.

18 May 2005

Patients who have a blood clot are at high risk of having another one, and men have more than twice the risk as women

While estimates of the overall risk of a thrombotic (blood clot) event recurrence vary, reports on contributing factors are contradictory, according to background information in the article. Knowledge of the risk of a thrombotic event recurrence and its determinants is relevant for clinical policy regarding screening for thrombophilia (increased risk for blood clot), duration of anticoagulant treatment, and treatment strategies in circumstances of increased risk.

17 May 2005

More research needed into access to emergency contraception

Experts at The University of Nottingham have called for more research into whether systems for accessing emergency contraception are meeting the needs of younger women and those from poorer backgrounds.

17 May 2005

Research findings help predict risk of blood clots in women receiving tamoxifen therapy for breast cancer

New research findings may help physicians determine which women have an increased risk of blood clots when taking tamoxifen for the management of breast cancer, a team led by Dana-Farber Cancer Institute investigators will report at the American Society of Clinical Oncology's annual meeting.

15 May 2005

GPs facing prosecution for handing out Pill to girls aged 10

Some Scottish doctors could be facing prosecution after it was revealed they have been prescribing the contraceptive pill to girls as young as ten.

9 May 2005

HIV treatment not affected by hormonal birth control

Estrogen and progesterone hormones in birth control do not influence the effectiveness of highly active antiretroviral therapy (HAART), which is used to treat HIV infection, according to researchers from the Johns Hopkins Bloomberg School of Public Health and other institutions. The study is published in the May 1, 2005, issue of the American Journal of Epidemiology.

2 May 2005

Emergency contraceptive Plan B now available over the counter in Canada

The emergency contraceptive drug Plan B will now be available over the counter in all of Canada as Health Canada yesterday ended the prescription requirement for Paladin Labs Inc.'s contraceptive.

20 Apr 2005

Compound derived from cottonseed oil could help improve the effectiveness of chemotherapy at treating head and neck cancer

The findings, which will be presented Tuesday, April 19, at the American Association for Cancer Research annual meeting, could lead to a treatment that provides an effective option to surgically removing the cancer, helping patients preserve vital organs involved in speech and swallowing.

19 Apr 2005

Hormonal contraceptives increase risk of HSV-2 transmission

Women who are infected with herpes simplex virus type 2 (HSV-2) may have an increased risk of transmitting the virus to others if they use hormonal contraceptives or have certain bacterial vaginal infections, according to an article in the May 15 issue of Clinical Infectious Diseases, now available online.

6 Apr 2005

Potential therapeutic target for infertility and contraception

The multiple “litter” births of mice, versus the normal singleton pregnancy of humans, is due to defective processing in mice of a common mammalian protein called bone morphogenetic protein 15 (BMP-15), according to new research from the University of California, San Diego (UCSD) School of Medicine.

5 Apr 2005

HIV/AIDS impacts on population dynamics and economic growth

Top officials at the United Nations Commission on Population and Development, at its yearly meeting are focussing on the negative effects of HIV/AIDS on population dynamics, including population losses and decreased life expectancy, as well as the pandemic's links to increased extreme poverty, stalled economic growth and poor reproductive health in many parts of the world.

5 Apr 2005

Late developers more at risk from sexually transmitted disease

Researchers at the Academic Unit of Obstetrics and Gynaecology, St Mary's Hospital, Manchester, UK, have found that late developers may run a higher risk of infection than sexually mature younger teens.

From The University of Manchester 3 Apr 2005

New drug approved for treating endometriosis

Drug manufacturer Pfizer announced today that the U.S. Food and Drug Administration (FDA) has given approval for the release of depo-subQ provera 104 to be prescribed for the management of pain associated with endometriosis, a gynecological condition that affects one in ten women of reproductive age.

30 Mar 2005

Pharmaceutical reproductive rights in the United States

The battle over reproductive rights in the United States has taken another turn with some pharmacists refusing to fill prescriptions for birth control and morning-after pills on the grounds that dispensing the medications violates their moral or religious beliefs.

29 Mar 2005